Assessment of Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Cases in Kuwait
- PMID: 33197912
- PMCID: PMC7900476
- DOI: 10.1159/000513047
Assessment of Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Cases in Kuwait
Abstract
Objective: The objective of this study was to assess the clinical characteristics and identify mortality risk factors in intensive care unit (ICU)-admitted COVID-19 patients.
Methods: We recruited and analyzed SARS-CoV-2-infected adult patients (age ≥18 years) who were admitted to the ICU at Jaber Al-Ahmad Al Sabah Hospital, Kuwait, between March 1, 2020, and April 30, 2020. The risk factors associated with in-hospital mortality were assessed using multiple regression analysis.
Results: We recruited a total of 103 ICU patients in this retrospective cohort. The median age of the patients was 53 years and the fatality rate was 45.6%; majority (85.5%) were males and 37% patients had more than 2 comorbidities. Preexisting hypertension, moderate/severe acute respiratory distress syndrome, lymphocyte count <0.5 × 109, serum albumin <22 g/L, procalcitonin >0.2 ng/mL, D-dimer >1,200 ng/mL, and the need for continuous renal replacement therapy were significantly associated with mortality.
Conclusion: This study describes the clinical characteristics and risk factors for mortality among ICU patients with CO-VID-19. Early identification of risk factors for mortality might help improve outcomes.
Keywords: Acute respiratory distress syndrome; Coronavirus infection; Pneumonia; SARS-CoV-2.
© 2020 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors declare to have no conflicts of interests.
References
-
- Outbreak was declared a Public Health Emergency of International concern by WHO 2020. Jan 30. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a.... - PMC - PubMed
-
- Kuwait confirms 3 coronavirus patients coming from Iran 2020. Feb 24. Available from: https://www.kuna.net.kw/ArticleDetails.aspx?id = 2864385&language = en.
-
- Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;323((18)):1824–36. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous